SmartPace™ is an imaging-based software platform that improves the management of patients with heart failure, a condition that affects 6 million Americans. The technology assesses whether a given patient will benefit from a pacemaker, and if so provides a prescription to guide the surgeon during implantation. SmartPace™ was developed by a team of bioengineers and cardiologists, including David Schwartzman, MD, with IP protection through Pitt.